Search is Powered by Google
MRI / PET / Ultrasound News

Unpleasant Arithmetic Of Medical Innovation

Main Category: MRI / PET / Ultrasound
Article Date: 31 Jul 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Three to five million central lines are placed into people's hearts in the United States every year. Some have complications, and these are costly. There are two methods of placement, ultrasound guided placement, and placement by hand, or the 'landmark' technique. Ultrasound guidance has fewer complications, but is more expensive. A recent study has asked how much would be saved in complications if every central line were placed by the ultrasound technique.

The study, "Ultrasound Guided Central Line Placement versus Standard Landmark Technique: Some Unpleasant Arithmetic for the Economics of Medical Innovation", set out to measure the cost of ultrasound guided central line placement using Medicare reimbursement data. This study, which is published in Value in Health, has costed-out the impact of these complications nationally based on US Medicare data reveals the initial 'cost' of placing central lines was found to be $390,780,000 - $651,300,000 dollars per year by the landmark technique, as compared to $494,820,000 - $824,700,000 dollars per year by ultrasound guidance. The study was co-authored by Stephen Kinsella and Nicholas Young, of the University of Limerick, Ireland, and Colorado, USA.

Says Dr. Young: "We hope this research spurs other costing studies in this area, at a time when curbing medical inflation has such a high national priority."

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research and help health care leaders to make decisions that are solidly evidence-based. The journal is published bi-monthly and has a regular readership of over 3,000 clinicians, decision-makers, and researchers worldwide.

ISPOR is a nonprofit, international organization that strives to translate pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce health care resources wisely, fairly, and efficiently.

Value in Health Volume 12 Issue 1 - January/February 2009
ABSTRACT

http://www.stephenkinsella.net
http://www.ispor.org




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
UltraShape(R) Commences Pivotal Study For First Non-Invasive Fat Reduction And Body Contouring Device Using Non-Thermal Selective Focused Ultrasound
15 Jun 2008
UltraShape®, a global leader in non-invasive fat reduction and body contouring, announced the commencement of its pivotal IDE (Investigational Device Exemption) study to evaluate Contour Plus™, the first...


When Your Cycle Becomes a Major Headache
When Your Cycle Becomes a Major Headache

Cathy's gets as many as 12 to 15 headaches a month and they are all associated with her menstrual cycle. Migraines like hers tend to last longer and be more severe than other migraines. Figuring out what was triggering her headaches helped Cathy and her doctor come up with a successful treatment plan.

more videos are available in our health videos section.